Immunohistochemistry-Paraffin: IgA2 Antibody (RM125) [Unconjugated] [NBP2-62025] - IgA2 stained human tonsil FFPE, 20X magnification. Antigen retrieval was performed with citrate pH 6 buffer. Primary antibody at 1:8000. ...read more
Immunohistochemistry: IgA2 Antibody (RM125) [Unconjugated] [NBP2-62025] - Immunohistochemistry of Human Tonsil Tissue using NBP2-62025.
ELISA: IgA2 Antibody (RM125) [Unconjugated] [NBP2-62025] - ELISA of human immunoglobulins shows NBP2-62025 only reacts to human IgA2. No cross reactivity with human IgA1, IgG, IgM, IgD, or IgE. The plate was coated with ...read more
ELISA: IgA2 Antibody (RM125) [Unconjugated] [NBP2-62025] - A titer ELISA using NBP2-62025. The plate was coated with different amounts of human IgA2. A serial dilution of NBP2-62025 was used as the primary antibody. An ...read more
ELISA: IgA2 Antibody (RM125) [Unconjugated] [NBP2-62025] - Sandwich ELISA using NBP2-62025 as the capture antibody, and biotinylated anti-human light chains (kappa+lambda) antibody (NBP2-77396) as the detection ...read more
Antigen retrieval was done with citrate pH6 for 15 mins at 100C and allowed to cool 30 minutes at room temperature. Primary was diluted 1:8000 and incubated at room temperature for 30 mins in Dako antibody diluent (S3022). Secondary ImmPRESS goat anti-rabbit HRP polymer was incubate 30 minutes at room temperature and signal was developed with SIgnalStain DAB chromagen.
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.